Martin L. D. L. T. C.
- Country
- Spain
- Department
- Endocrinology
Research Overview
Data & Insights
Has run more than one trial at 36 of 103 partner sites.
Specializations
Diabetes Management
The investigator specializes in the clinical evaluation of innovative therapies for Type 2 Diabetes Mellitus, with particular emphasis on treatments that may offer cardiovascular benefits.
- Glucose Control Optimization
- Cardiovascular Risk Management
- Metabolic Disease Treatment
Their research focuses on comparing emerging therapeutic options with established treatments in diabetes care.
Cardiovascular Outcomes
The investigator studies the impact of diabetes medications on major cardiovascular events, including mortality, myocardial infarction, and stroke in high-risk patients.
- Cardiovascular Risk Assessment
- Mortality Prevention
- Stroke Prevention
Their work involves evaluating cardiovascular safety profiles of diabetes treatments in long-term clinical research.
Therapeutic Innovation
The investigator evaluates novel incretin-based therapies for diabetes management, focusing on their potential to improve both glycemic control and cardiovascular outcomes.
- Novel Drug Development
- Treatment Optimization
- Standard of Care Enhancement
Their research encompasses the assessment of innovative therapeutic approaches in diabetes care.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.